Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Reconciliation of Fair Value of Liabilities (Details)

v3.21.2
Fair Value of Financial Instruments - Reconciliation of Fair Value of Liabilities (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Contingent Consideration  
Beginning balance $ 0
Contingent consideration issued for Eyce acquisition 1,828
Loss from fair value adjustments included in results of operations 755
Ending balance $ 2,583